Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

More in Gastroenterology

For the past few decades, alpha-1 antitrypsin deficiency (AATD) treatment has been mostly limited to enzyme therapy. While this type of therapy is able to treat symptoms of emphysema and COPD and may even be disease modifying, there is hope that...
For the past few decades, clinical trials related to alpha-1 antitrypsin deficiency (AATD), have focused on getting more replacement therapy on the market. New areas of AATD research focus on gene therapy for lung disease and RNA interference for liver...
Bruce Given, MD explains how alpha-1 antitrypsin deficiency (AATD) is most often associated with pulmonary disease in adults and liver disease in children. However, as treatment of adults with AATD has improved, these patients are living longer and often...